PortfoliosStock ScreensStocksStockXcel

Sunshine Biopharma Inc. Warrant

SBFMW | US

0.09

USD

0

0%

SBFMW | US
Loading StockChartView...

About Sunshine Biopharma Inc. Warrant

Sector

Healthcare

Industry

Drug Manufacturers-Specialty & Generic

Earnings date

30/06/2024

As of date

24/03/2026

Close

0.09

Open

0.09

High

0.09

Low

0.09

Sunshine Biopharma Inc. a pharmaceutical company focuses on the research and development of life-saving medicines in various therapeutic areas including oncology and antivirals. The company is developing Adva-27a a GEM-difluorinated C-glycoside derivative of podophyllotoxin to treat leukemia lymphoma testicular lung brain prostate bladder colon ovarian liver and other forms of cancers as well as kills multidrug resistant cancer cells including pancreatic cancer breast cancer small-cell lung cancer and uterine sarcoma cells; SBFM-PL4 an anti-coronavirus treatment compound; and K1.1 mRNA molecules used as anti-cancer agents. It also offers Essential 9 an amino acids capsules; and Calcium-Vitamin D supplement under the Essential Calcium-Vitamin D brand name as well as develops and markets other science-based nutritional supplements. Sunshine Biopharma Inc. is based in Pointe-Claire Canada.

View Less

SBFMW | US

Risk
304.9
Sharpe
-0.16
Luna's Score
46/100
Recommendation
Hold

Luna says (SBFMW | US)

What's Working

Low Debt to Equity (< 0.25)

Low Debt to Asset (< 0.2)

Strong Revenue Growth (> 10%)

What's not Working

Price Below SMA10D

High Short-term Volatility

High 6-Month Volatility (>65%)

Microcap (<300M USD)

Low negative Beta, possible Low Liquidity (< -0.4)

Weak Operating Margin (< 10%)

Weak Sharpe Ratio (< 0.3)

Volatility Signals

Bearish: Increased Volatility (6-month > 1-month volatility)

Risk Meter

Loading RiskMeterView...

10 days

306.4%

1 month

304.9%

3 months

292.4%

6 months

315.6%

Returns

Loading ReturnMeterView...

Fundamental Ratios

PE

-

Fwd. PE

-

Price to book

-

Debt to equity

0.02

Debt to assets

0.02

Ent. to EBITDA

-

Ent. to rev.

-

PEG

-

Other Fundamentals

EBITDA

-4.40M

MarketCap

-

MarketCap(USD)

-

Div. yield

-

Op. margin

-13.63

Erngs. growth

-

Rev. growth

67.30

Ret. on equity

-15.79

Short ratio

-

Short perc.

-

Market Sentiment (SMA and Price signals)

Short-term: Bearish (SMA10D < SMA1M)

Intermediate-term: Bearish (SMA1M < SMA3M)

Long-term: Bearish (SMA6M < SMA12M)

SMAs: Stock Price Trends

Loading MovingAverageView...

Range10D

0.03

Range1M

0.19

Range3M

0.19

Volumes: Market Activity

Volume Averages

Loading VolumeAverageView...

Rel. volume

0.60

Price X volume

493.15

Peers

Name
Ticker
Industry
Close
Marketcap
Day Return
PE Ratio
Debt to Equity
 
 
 
 
 
 
 
 
CURE Pharmaceutical Holding CorpCURRDrug Manufacturers-Specialty & Generic2.4701.65%n/a
  • 1

Diversifiers

Name
Ticker
Industry
Close
Marketcap
Day Return
PE Ratio
Debt to Equity
 
 
 
 
 
 
 
 
Blackstone/GSO Senior Floating Rate Term FundBSLTextile Manufacturing12.800.27%n/a
  • 1

Industry Comparison

ParameterCompanyIndustryIndicator
Enterprise to EBITDA-24.85-
Ent. to Revenue-361.91-
PE Ratio-30.05-
Price to Book-13.15-
Dividend Yield-2.94-
Std. Deviation (3M)292.4265.24Riskier
Debt to Equity0.02-1.88Expensive
Debt to Assets0.020.48Cheaper
Market Cap-3.71B-
  • 1

Unlock Your Investing Potential

Register with Xstocks

Join over 2,000+ Investors

Register now and embark on your journey to informed and successful investing.

Explore Industry Correlations

Explore Industry Correlations

Uncover Trading and Hedging Opportunities

Gain valuable insights into potential trading opportunities and discover strategic hedging possibilities

Discover Top-Performing Industries

Discover Top performing Industries

Explore Stocks for Short and Long-Term Gains

Uncover opportunities at both short-term and long-term horizons, allowing you to make informed investment decisions.

Follow us @XStocks007